Adjuvant immunotherapy in resected esophageal squamous cell carcinoma: a gospel to the non-pCRs

被引：3
|
作者：
Zhang, Zhihui [1 ,2 ]
Sun, Nan [1 ,2 ]
He, Jie [1 ,2 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Thorac Surg,Natl Canc Ctr, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, State Key Lab Mol Oncol,Natl Canc Ctr, Beijing, Peoples R China
来源：
SIGNAL TRANSDUCTION AND TARGETED THERAPY | 2021年 / 6卷 / 01期
关键词：
D O I：
10.1038/s41392-021-00722-0
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Adjuvant immunotherapy in resected esophageal squamous cell carcinoma: a gospel to the non-pCRs
    Zhihui Zhang
    Nan Sun
    Jie He
    [J]. Signal Transduction and Targeted Therapy, 6
  • [2] Immunotherapy for Esophageal Squamous Cell Carcinoma
    Kojima, Takashi
    Doi, Toshihiko
    [J]. CURRENT ONCOLOGY REPORTS, 2017, 19 (05)
  • [3] Immunotherapy for Esophageal Squamous Cell Carcinoma
    Takashi Kojima
    Toshihiko Doi
    [J]. Current Oncology Reports, 2017, 19
  • [4] The impact of adjuvant radiotherapy on radically resected T3 esophageal squamous cell carcinoma
    Chen, Shao-bin
    Weng, Hong-rui
    Wang, Geng
    Liu, Di-tian
    Li, Hua
    Zhang, Hao
    Chen, Yu-ping
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (01) : 277 - 286
  • [5] Optimal Adjuvant Treatment for Curatively Resected Thoracic Esophageal Squamous Cell Carcinoma: A Radiotherapy Perspective
    Kim, Kyung Hwan
    Chang, Jee Suk
    Cha, Ji Hye
    Lee, Lk Jae
    Kim, Dae Joon
    Cho, Byoung Chul
    Park, Kyung Ran
    Lee, Chang Geol
    [J]. CANCER RESEARCH AND TREATMENT, 2017, 49 (01): : 168 - 177
  • [6] The impact of adjuvant radiotherapy on radically resected T3 esophageal squamous cell carcinoma
    Shao-bin Chen
    Hong-rui Weng
    Geng Wang
    Di-tian Liu
    Hua Li
    Hao Zhang
    Yu-ping Chen
    [J]. Journal of Cancer Research and Clinical Oncology, 2016, 142 : 277 - 286
  • [7] Immunotherapy for esophageal squamous cell carcinoma : a review
    Mimura, Kosaku
    Yamada, Leo
    Ujiie, Daisuke
    Hayase, Suguru
    Tada, Takeshi
    Hanayama, Hiroyuki
    Min, Aung Kyi Thar
    Shibata, Masahiko
    Momma, Tomoyuki
    Saze, Zenichiro
    Ohki, Shinji
    Kono, Koji
    [J]. FUKUSHIMA JOURNAL OF MEDICAL SCIENCE, 2018, 64 (02) : 46 - 53
  • [8] Perioperative immunotherapy for esophageal squamous cell carcinoma
    Wei, Dan D.
    Fang, Jin M.
    Wang, Huan Z.
    Chen, Jian
    Kong, Shuai
    Jiang, Yan-Yi
    Jiang, Yuan
    [J]. FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [9] ADJUVANT IMMUNOTHERAPY WITH LEVAMISOLE IN RESECTED, THEN IRRADIATED SQUAMOUS-CELL BRONCHIAL-CARCINOMA - A RANDOMIZED STUDY
    ROESLIN, N
    LANG, JM
    WIHLM, JM
    MORAND, G
    WITZ, JP
    [J]. PRESSE MEDICALE, 1984, 13 (23): : 1461 - 1462
  • [10] Is adjuvant immunotherapy a new standard for non-pathological complete response patients with resectable esophageal squamous cell carcinoma?
    Wang, Jun
    Hui, Zhouguang
    Pang, Qingsong
    [J]. THORACIC CANCER, 2022, 13 (21) : 3099 - 3100
12345